Caliper Technologies, Pharmacopeia Added to Nasdaq Biotech Index | GenomeWeb

NEW YORK, May 14 – Caliper Technologies and Pharmacopeia will be among seven new companies included in the Nasdaq Biotechnology Index as of marketing opening May 21, Nasdaq announced on Monday. 

Companies included in the Index are evaluated semi-annually for minimum price, market value, and average daily share volume requirements.

Sixteen companies will be removed, including Lexicon Genetics. The Woodlands, Texas-based company on May 8 announced flat revenues first-quarter 2001 compared to the year-ago quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.